Dr. Reddy’s and Hetero join hands with Gilead to broaden access to HIV drug Lenacapavir in low-income countries
The tie up will enable the company to distribute the drug to 120 countries with low and lower-middle income
The tie up will enable the company to distribute the drug to 120 countries with low and lower-middle income